PD-1/PD-L1 Inhibitors plus Chemotherapy Versus Chemotherapy Alone for Resectable Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

SIMPLE SUMMARY: Immunotherapy, particularly programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors, has been responsible for changing the natural history of advanced or metastatic non-small cell lung cancer. However, its use in the resectable stage is not yet fully e...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasqualotto, Eric, de Moraes, Francisco Cezar Aquino, Chavez, Matheus Pedrotti, Souza, Maria Eduarda Cavalcanti, Rodrigues, Anna Luíza Soares de Oliveira, Ferreira, Rafael Oliva Morgado, Lopes, Lucca Moreira, de Almeida, Artur Menegaz, Fernandes, Marianne Rodrigues, dos Santos, Ney Pereira Carneiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648147/
https://www.ncbi.nlm.nih.gov/pubmed/37958317
http://dx.doi.org/10.3390/cancers15215143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648147/
https://www.ncbi.nlm.nih.gov/pubmed/37958317
http://dx.doi.org/10.3390/cancers15215143

Ejemplares similares